329 related articles for article (PubMed ID: 29933901)
1. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
2. [GHB withdrawal delirium].
Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
[TBL] [Abstract][Full Text] [Related]
3. Baclofen and gamma-hydroxybutyrate withdrawal.
LeTourneau JL; Hagg DS; Smith SM
Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
[TBL] [Abstract][Full Text] [Related]
4. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
[TBL] [Abstract][Full Text] [Related]
5. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series.
Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J
Drug Alcohol Rev; 2023 Jan; 42(1):27-32. PubMed ID: 36269081
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
7. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
Rosenberg MH; Deerfield LJ; Baruch EM
Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
10. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
Woods AD; Giometti R; Weeks SM
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
12. Gamma-hydroxybutyrate withdrawal syndrome.
Dyer JE; Roth B; Hyma BA
Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
14. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
15. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
[TBL] [Abstract][Full Text] [Related]
16. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
[TBL] [Abstract][Full Text] [Related]
18. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
Habibian S; Ahamad K; McLean M; Socias ME
J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
[TBL] [Abstract][Full Text] [Related]
19. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
20. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
